00000000cam 2200000zi 4500
0019.957671
003CaOODSP
00520260319150749
006m     o  d f      
007cr cn|||||||||
008251125e202601##onc     ob   f000 0 eng d
020 |a9780660799032 |q(statement)
020 |a9780660799049 |q(summary)
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-396/2025E-PDF
0861 |aHP40-396/2025-1E-PDF
24500|aUpdated guidance for use of rabies vaccine for pre-exposure prophylaxis (PrEP).
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cJanuary 2026.
264 4|c©2026
300 |a1 online resource (51 pages) + |esummary (5 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Directives mises à jour sur l'utilisation des vaccins contre la rage pour la prophylaxie préexposition (PPrE).
500 |a"An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI)"--Cover.
500 |a"Pub.: 250365"--Page 2 (summary).
500 |aThe publication file in PDF format has been replaced on 19 March 2026 as requested by the Public Health Agency of Canada.
504 |aIncludes bibliographical references (pages 45-51).
650 0|aRabies|xVaccination|xGovernment policy|zCanada.
650 0|aRabies vaccines|xGovernment policy|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
7101 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body.
77508|tDirectives mises à jour sur l'utilisation des vaccins contre la rage pour la prophylaxie préexposition (PPrE).|w(CaOODSP)9.957672
85640|qPDF|s669 KB|uhttps://publications.gc.ca/collections/collection_2026/aspc-phac/HP40-396-2025-eng.pdf|zStatement
85640|qPDF|s212 KB|uhttps://publications.gc.ca/collections/collection_2026/aspc-phac/HP40-396-2025-1-eng.pdf|zSummary
986 |a250365